Among the genes responsible for somatic mutations in non‐small‐cell lung cancer (NSCLC), the most frequent driver oncogenes were epidermal growth factor receptor (EGFR), v‐Ki‐ras2 Kirsten rat sarcoma (KRAS), and tumor protein p53 (TP53). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.